QuidelOrtho Corporation
QDEL
QuidelOrtho Corporation focuses on the development and manufacture of diagnostic testing technologies across the continuum of healthcare testing needs. The company operates through Labs, Transfusion Medicine, Point-of-Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tests that measure target chemicals in bodily fluids forā¦ read more
Healthcare
Medical Instruments & Supplies
35 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$14.85
Price+7.61%
$1.05
1Y
Price
Market Cap
$1.013b
Small
Price/Earnings 3y Avg5y Avg
11.1x
Premium
Premium
Financial Reports
Key metrics over the past few years and other important metrics. Amounts in USD.+13.1%
EBITDA Margin-14.8%
Net Profit Margin-4.3%
Free Cash Flow Margin+13.1%
EBITDA Margin-14.8%
Net Profit Margin-4.3%
Free Cash Flow MarginRevenue
$2.657b
-2.7%
1y CAGR-3.9%
3y CAGR-5.0%
5y CAGREarnings
-$1.211b
-7.0%
1y CAGR-6726.3%
3y CAGR-5070.2%
5y CAGREPS
-$17.85
-7.0%
1y CAGR-6740.5%
3y CAGR-5080.8%
5y CAGRBook Value
$1.851b
$5.629b
Assets$3.777b
Liabilities$2.875b
DebtDebt to Assets
51.1%
-5.2x
Debt to EBITDAFree Cash Flow
-$75.200m
+9.4%
1y CAGR-74.2%
3y CAGR-78.3%
5y CAGRNo items found.
Press Releases
Statements and updates from the company